首页 > 最新文献

Journal of Translational Critical Care Medicine最新文献

英文 中文
Neurotoxicity Associated with Cefepime: An Update to Neurocritical Care: A Narrative Review 与头孢吡肟相关的神经毒性:神经危重症护理的更新:叙述性回顾
Pub Date : 2020-04-01 DOI: 10.4103/jtccm.jtccm_21_20
L. Moscote-Salazar, Amrita Ghosh, R. Pal, S. Raj, M. Rahman, A. Agrawal
Neurotoxicity has been an adverse effect described for almost all B-lactams; since its launch in 1994, there are numerous reports of patients treated with cefepime, covering a wide spectrum of clinical manifestations ranging from delirium to a nonconvulsive status epilepticus (NCSE), being the most of them reported in patients with decreased renal function, but also in patients with preserved renal function. We attempted to illustrate the clinical spectrum of cefepime neurotoxicity in relation to neurocritical care. We identified 13 publications describing neurotoxicity following cefepime administration from PubMed using search terms were cefepime, neurotoxicity, seizures, delirium, encephalopathy, NCSE, myoclonus, confusion, aphasia, agitation, coma, disability, and death. Two reviewers independently assessed identified articles for eligibility and used for this review writing. Most reports occur in elderly patients, although cases have been described in children and newborns. In general, patients recover soon after stopping beta-lactams or after reducing the dose or replacing them with another antibiotic; however, there is a likelihood of recurrence of symptoms after reintroducing Cefepime again at a dose low.
神经毒性已被描述为几乎所有b -内酰胺的不良反应;自1994年上市以来,有大量关于头孢吡肟治疗患者的报告,涵盖了从谵妄到非惊厥性癫痫持续状态(NCSE)的广泛临床表现,其中大多数报告用于肾功能下降的患者,但也用于肾功能保留的患者。我们试图说明头孢吡肟与神经危重症护理相关的神经毒性的临床谱。我们从PubMed检索了13篇描述头孢吡肟给药后神经毒性的出版物,检索词为头孢吡肟、神经毒性、癫痫发作、谵妄、脑病、NCSE、肌颤、精神错乱、失语、躁动、昏迷、残疾和死亡。两名审稿人独立评估已确定的文章的合格性并用于本综述写作。大多数报告发生在老年患者中,尽管在儿童和新生儿中也有病例。一般来说,患者在停止β -内酰胺类药物或减少剂量或用另一种抗生素替代后很快康复;然而,低剂量再次使用头孢吡肟后,有可能出现症状复发。
{"title":"Neurotoxicity Associated with Cefepime: An Update to Neurocritical Care: A Narrative Review","authors":"L. Moscote-Salazar, Amrita Ghosh, R. Pal, S. Raj, M. Rahman, A. Agrawal","doi":"10.4103/jtccm.jtccm_21_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_21_20","url":null,"abstract":"Neurotoxicity has been an adverse effect described for almost all B-lactams; since its launch in 1994, there are numerous reports of patients treated with cefepime, covering a wide spectrum of clinical manifestations ranging from delirium to a nonconvulsive status epilepticus (NCSE), being the most of them reported in patients with decreased renal function, but also in patients with preserved renal function. We attempted to illustrate the clinical spectrum of cefepime neurotoxicity in relation to neurocritical care. We identified 13 publications describing neurotoxicity following cefepime administration from PubMed using search terms were cefepime, neurotoxicity, seizures, delirium, encephalopathy, NCSE, myoclonus, confusion, aphasia, agitation, coma, disability, and death. Two reviewers independently assessed identified articles for eligibility and used for this review writing. Most reports occur in elderly patients, although cases have been described in children and newborns. In general, patients recover soon after stopping beta-lactams or after reducing the dose or replacing them with another antibiotic; however, there is a likelihood of recurrence of symptoms after reintroducing Cefepime again at a dose low.","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"129 1","pages":"28 - 35"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87950941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative Myxedema Coma: A Rare Presentation of Hypothyroidism 术后黏液性水肿昏迷:甲状腺功能减退的一种罕见表现
Pub Date : 2020-04-01 DOI: 10.4103/jtccm.jtccm_13_20
Mafdy N. Basta
Myxedema coma is a rare life-threatening form of severe hypothyroidism with physiological decompensation. It occurs as a result of long-standing, undiagnosed, or undertreated hypothyroidism and is usually precipitated by an acute event similar to infection, cerebrovascular accident, myocardial infarction, trauma, cold exposure, surgery, or drug therapy. Patients with myxedema coma are generally severely ill with hypothermia and depressed mental status. It is a medical emergency with a high mortality rate. If the diagnosis is suspected, immediate management is necessary before confirming the diagnosis. Patients with myxedema coma should be treated in an intensive care unit with continuous cardiac monitoring. Initial steps in management include airway management, thyroid hormone replacement, glucocorticoid therapy, and supportive measures. Fortunately, it is now a rare presentation of hypothyroidism, likely due to earlier diagnosis as a result of the widespread availability of thyroid-stimulating hormone assays. The following presentation is a case of postoperative myxedema coma that was successfully managed with multidisciplinary effort. The patient has had a complete recovery.
黏液性水肿昏迷是一种罕见的危及生命的严重甲状腺功能减退与生理代偿失调。它是长期未确诊或治疗不足的甲状腺功能减退症的结果,通常由急性事件引起,如感染、脑血管意外、心肌梗死、创伤、寒冷暴露、手术或药物治疗。黏液水肿昏迷的患者通常病情严重,伴有体温过低和精神状态低落。这是一种死亡率很高的医疗紧急情况。如果怀疑诊断,在确认诊断之前,需要立即进行治疗。黏液水肿昏迷患者应在重症监护病房接受持续心脏监测。治疗的最初步骤包括气道管理、甲状腺激素替代、糖皮质激素治疗和支持措施。幸运的是,这是一种罕见的甲状腺功能减退的表现,可能是由于早期诊断的结果,广泛使用促甲状腺激素检测。以下是一例术后黏液性水肿昏迷,经多学科努力成功治疗。病人已经完全康复了。
{"title":"Postoperative Myxedema Coma: A Rare Presentation of Hypothyroidism","authors":"Mafdy N. Basta","doi":"10.4103/jtccm.jtccm_13_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_13_20","url":null,"abstract":"Myxedema coma is a rare life-threatening form of severe hypothyroidism with physiological decompensation. It occurs as a result of long-standing, undiagnosed, or undertreated hypothyroidism and is usually precipitated by an acute event similar to infection, cerebrovascular accident, myocardial infarction, trauma, cold exposure, surgery, or drug therapy. Patients with myxedema coma are generally severely ill with hypothermia and depressed mental status. It is a medical emergency with a high mortality rate. If the diagnosis is suspected, immediate management is necessary before confirming the diagnosis. Patients with myxedema coma should be treated in an intensive care unit with continuous cardiac monitoring. Initial steps in management include airway management, thyroid hormone replacement, glucocorticoid therapy, and supportive measures. Fortunately, it is now a rare presentation of hypothyroidism, likely due to earlier diagnosis as a result of the widespread availability of thyroid-stimulating hormone assays. The following presentation is a case of postoperative myxedema coma that was successfully managed with multidisciplinary effort. The patient has had a complete recovery.","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"60 1","pages":"41 - 45"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88512227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Desmopressin in Critically Ill Neurosurgical Patients: An Overview 去氨加压素在神经外科危重病人中的应用综述
Pub Date : 2020-04-01 DOI: 10.4103/jtccm.jtccm_14_20
Angie Ching-Gonzalez, Christian Meza-Valle, Karen Muñoz-Báez, Juan Medrano-Carreazo, A. Agrawal, Rakesh Mishra, Adesh Shrivastava, Tariq Janjua, L. Moscote-Salazar
Severely ill neurosurgical patients are those who present with pathologies of the nervous system associated with either a high mortality or that which leaves significant sequelae in those who survive. Desmopressin is a synthetic analog of the antidiuretic hormone that is stored in neurohypophysis. Its function is to decrease urinary volume by increasing reabsorption of water in the convoluted tubules and nephron collectors, additionally increasing the expression of coagulation factor VII and the von Willebrand factor. For this reason, its usefulness in the management of various pathologies has been tested, from coagulopathies to posttraumatic and postsurgical diabetes insipidus. It contributes in improving hyponatremia and in maintaining the balance of fluids and electrolytes in traumatic brain injury and subarachnoid hemorrhage (SAH) patients. It has been additionally studied for its role in the risk of rebleeding in SAH patients and in those with coagulopathies, where its implicated mechanism of action is through platelet anti-aggregation.
严重的神经外科病人是那些表现出与高死亡率或在存活者中留下显著后遗症相关的神经系统病理的病人。去氨加压素是储存在神经垂体中的抗利尿激素的合成类似物。它的功能是通过增加水在曲小管和肾元收集器的重吸收来减少尿量,另外增加凝血因子VII和血管性血友病因子的表达。由于这个原因,它在各种病理管理的有用性已经被测试,从凝血病到创伤后和手术后尿崩症。它有助于改善创伤性脑损伤和蛛网膜下腔出血(SAH)患者的低钠血症和维持液体和电解质平衡。此外,还研究了它在SAH患者和凝血功能障碍患者再出血风险中的作用,其中它的作用机制是通过血小板抗聚集。
{"title":"Desmopressin in Critically Ill Neurosurgical Patients: An Overview","authors":"Angie Ching-Gonzalez, Christian Meza-Valle, Karen Muñoz-Báez, Juan Medrano-Carreazo, A. Agrawal, Rakesh Mishra, Adesh Shrivastava, Tariq Janjua, L. Moscote-Salazar","doi":"10.4103/jtccm.jtccm_14_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_14_20","url":null,"abstract":"Severely ill neurosurgical patients are those who present with pathologies of the nervous system associated with either a high mortality or that which leaves significant sequelae in those who survive. Desmopressin is a synthetic analog of the antidiuretic hormone that is stored in neurohypophysis. Its function is to decrease urinary volume by increasing reabsorption of water in the convoluted tubules and nephron collectors, additionally increasing the expression of coagulation factor VII and the von Willebrand factor. For this reason, its usefulness in the management of various pathologies has been tested, from coagulopathies to posttraumatic and postsurgical diabetes insipidus. It contributes in improving hyponatremia and in maintaining the balance of fluids and electrolytes in traumatic brain injury and subarachnoid hemorrhage (SAH) patients. It has been additionally studied for its role in the risk of rebleeding in SAH patients and in those with coagulopathies, where its implicated mechanism of action is through platelet anti-aggregation.","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"133 ","pages":"23 - 27"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72426862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Severe Burns Complicated by Acute Kidney Injury: Some Nuances Regarding Risk Factors and Mortality Rate 严重烧伤并发急性肾损伤:危险因素和死亡率的一些细微差别
Pub Date : 2020-04-01 DOI: 10.4103/jtccm.jtccm_9_20
P. Honore, A. Mugisha, L. Kugener, S. Redant, R. Attou, A. Gallerani, D. Bels
{"title":"Severe Burns Complicated by Acute Kidney Injury: Some Nuances Regarding Risk Factors and Mortality Rate","authors":"P. Honore, A. Mugisha, L. Kugener, S. Redant, R. Attou, A. Gallerani, D. Bels","doi":"10.4103/jtccm.jtccm_9_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_9_20","url":null,"abstract":"","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"20 1","pages":"46 - 46"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80192590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features and Predictors for Outcome in Critically Ill Patients with COVID-19 Infection from Wuhan, China 武汉地区COVID-19感染危重患者临床特征及预后预测因素
Pub Date : 2020-01-01 DOI: 10.4103/jtccm.jtccm_28_20
Bo Hu, Dawei Wang, Chang Hu, Ming Hu, Fangfang Zhu, Hui Xiang, Beilei Zhao, K. Kashani, Z. Peng
Objective: The information about the critically ill coronavirus disease 2019 (COVID-19) was limited and controversy. This study was to analyze the clinical feature and predictors for outcome in critically ill COVID-19. Design: This was a descriptive study from two hospitals. Setting: This study was conducted in intensive care units (ICUs) from university hospitals. Methods: Critically ill COVID-19 patients admitted in ICU from Zhongnan Hospital of Wuhan University and Wuhan Pulmonary Hospital from January 8 to February 20, 2020, were screened. Interventions: None. Measurements and Main Results: Clinical, laboratory data were collected with management strategies and outcomes. Sixty-eight critically ill patients were enrolled. Their median age was 64 (interquartile range, 54–72) years, and 67.65% were male. In this cohort, 44 (65%) patients survived for 28 days. The invasive mechanical ventilator was used in 51 (75%) patients, with 20 of them requiring prone positioning, and 17 switched to extracorporeal membrane oxygenation. The compliance scores of lungs on the day of intubation among survivors were higher than those in nonsurvivors (25.00 [13.50–39.00] vs. 17.00 [12.00–22.00], P = 0.01). The blood interlukin-6 (IL-6) levels at the ICU admission were significantly higher in nonsurvivors compared to survivors (71.27 [51.48–144.15] vs. 18.15 [7.55–68.02] ng/ml, P = 0.025). The heart rates, lung injury scale, and positive end-expiratory pressure were constantly higher for 10 days in nonsurvivors. The frequency of vasopressor uses and neuromuscular blockers was higher in nonsurvivors from day 5 to day 10 (P < 0.05). In the whole cohort, the most common complications were acute respiratory distress syndrome (95.59%), shock (48.53%), arrhythmia (33.82%), acute cardiac injury (33.82%), and acute kidney injury (27.94%). Multivariate analysis indicated that lower lung compliance at the day of intubation and higher Acute Physiology and Chronic Health Evaluation II (APACHE II) at ICU admission were related to higher mortality (P = 0.02 and 0.05, respectively). Conclusion: COVID-19-related critical illness predominantly affected old individuals and was characterized by severe hypoxemic respiratory failure, often requiring prolonged mechanical ventilation and rescue therapies. High APACHE II scores and low lung compliance indicated poor outcomes.
目的:关于2019年新冠肺炎(COVID-19)的信息有限且存在争议。本研究旨在分析危重患者COVID-19的临床特征及预后预测因素。设计:这是一项来自两家医院的描述性研究。环境:本研究在大学医院的重症监护病房(icu)进行。方法:对2020年1月8日至2月20日武汉大学中南医院和武汉市肺科医院ICU收治的COVID-19危重症患者进行筛查。干预措施:没有。测量方法和主要结果:收集临床、实验室数据,并给出处理策略和结果。68名危重患者入组。年龄中位数为64岁(四分位数间54 ~ 72岁),67.65%为男性。在这个队列中,44例(65%)患者存活了28天。51例(75%)患者使用有创机械呼吸机,其中20例需要俯卧位,17例切换为体外膜氧合。存活组插管当日肺顺应性评分高于非存活组(25.00 [13.50-39.00]vs. 17.00 [12.00-22.00], P = 0.01)。ICU入院时,非存活组患者血液中白细胞介素-6 (IL-6)水平明显高于存活组(71.27 [51.48 ~ 144.15]vs. 18.15 [7.55 ~ 68.02] ng/ml, P = 0.025)。非幸存者的心率、肺损伤量表和呼气末正压持续升高10天。从第5天到第10天,非幸存者使用血管加压素和神经肌肉阻滞剂的频率更高(P < 0.05)。在整个队列中,最常见的并发症是急性呼吸窘迫综合征(95.59%)、休克(48.53%)、心律失常(33.82%)、急性心脏损伤(33.82%)和急性肾损伤(27.94%)。多因素分析显示,插管当日肺顺应性较低、入院时急性生理与慢性健康评估ⅱ(APACHEⅱ)较高与死亡率升高相关(P值分别为0.02和0.05)。结论:新型冠状病毒肺炎相关危重疾病以老年人为主,以严重低氧性呼吸衰竭为特征,常需要长时间机械通气和抢救治疗。APACHEⅱ评分高,肺顺应性低,预后较差。
{"title":"Clinical Features and Predictors for Outcome in Critically Ill Patients with COVID-19 Infection from Wuhan, China","authors":"Bo Hu, Dawei Wang, Chang Hu, Ming Hu, Fangfang Zhu, Hui Xiang, Beilei Zhao, K. Kashani, Z. Peng","doi":"10.4103/jtccm.jtccm_28_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_28_20","url":null,"abstract":"Objective: The information about the critically ill coronavirus disease 2019 (COVID-19) was limited and controversy. This study was to analyze the clinical feature and predictors for outcome in critically ill COVID-19. Design: This was a descriptive study from two hospitals. Setting: This study was conducted in intensive care units (ICUs) from university hospitals. Methods: Critically ill COVID-19 patients admitted in ICU from Zhongnan Hospital of Wuhan University and Wuhan Pulmonary Hospital from January 8 to February 20, 2020, were screened. Interventions: None. Measurements and Main Results: Clinical, laboratory data were collected with management strategies and outcomes. Sixty-eight critically ill patients were enrolled. Their median age was 64 (interquartile range, 54–72) years, and 67.65% were male. In this cohort, 44 (65%) patients survived for 28 days. The invasive mechanical ventilator was used in 51 (75%) patients, with 20 of them requiring prone positioning, and 17 switched to extracorporeal membrane oxygenation. The compliance scores of lungs on the day of intubation among survivors were higher than those in nonsurvivors (25.00 [13.50–39.00] vs. 17.00 [12.00–22.00], P = 0.01). The blood interlukin-6 (IL-6) levels at the ICU admission were significantly higher in nonsurvivors compared to survivors (71.27 [51.48–144.15] vs. 18.15 [7.55–68.02] ng/ml, P = 0.025). The heart rates, lung injury scale, and positive end-expiratory pressure were constantly higher for 10 days in nonsurvivors. The frequency of vasopressor uses and neuromuscular blockers was higher in nonsurvivors from day 5 to day 10 (P < 0.05). In the whole cohort, the most common complications were acute respiratory distress syndrome (95.59%), shock (48.53%), arrhythmia (33.82%), acute cardiac injury (33.82%), and acute kidney injury (27.94%). Multivariate analysis indicated that lower lung compliance at the day of intubation and higher Acute Physiology and Chronic Health Evaluation II (APACHE II) at ICU admission were related to higher mortality (P = 0.02 and 0.05, respectively). Conclusion: COVID-19-related critical illness predominantly affected old individuals and was characterized by severe hypoxemic respiratory failure, often requiring prolonged mechanical ventilation and rescue therapies. High APACHE II scores and low lung compliance indicated poor outcomes.","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"8 1","pages":"10 - 17"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84289841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optic Nerve Ultrasonography for Noninvasive Monitoring of Intracranial Pressure in COVID-19 Patients 视神经超声无创监测新冠肺炎患者颅内压
Pub Date : 2020-01-01 DOI: 10.4103/jtccm.jtccm_11_20
L. Moscote-Salazar, Tariq Janjua, A. Agrawal
century. Pediatr Res 2004;56:1-5. 3. Al Hajjar S, McIntosh K. The first influenza pandemic of the 21st century. Ann Saudi Med 2010;30:1-0. 4. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-90. 5. Sharifi‐Razavi A, Karimi N, Rouhani N. COVID‐19 and intracerebral haemorrhage: Causative or coincidental? New Microbes New Infect 2020;35:100669. 6. Beal JC. Increased intracranial pressure in the setting of Enterovirus and other viral meningitides. Neurol Res Int 2017;2017:2854043. 7. Svedung Wettervik T, Kumlien E, Rostami E, Howells T, von Seth M, Velickaite V, et al. Intracranial pressure dynamics and cerebral vasomotor reactivity in coronavirus disease 2019 patient with acute encephalitis. Crit Care Explor 2020;2:e0197. 8. Noro F, Cardoso FM, Marchiori E. COVID-19 and benign intracranial hypertension: A case report. Rev Soc Bras Med Trop 2020;53:e20200325. 9. Bhaskar S, Bradley S, Israeli-Korn S, Menon B, Chattu VK, Thomas P, et al. Chronic neurology in COVID-19 era: Clinical considerations and recommendations from the REPROGRAM consortium. Front Neurol 2020;11:664. 10. Lawrenson JG, Buckley RJ. COVID-19 and the eye. Ophthalmic Physiol Opt 2020;40:383-8. 11. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, et al. Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring. J Neurotrauma 2007;24 Suppl 1:S37-44. Dear Editor,
世纪。儿科杂志2004;56:1-5。3.Al Hajjar S, McIntosh K. 21世纪的第一次流感大流行。安沙特阿拉伯医学2010;30:1-0。4. 毛磊,金辉,王敏,胡勇,陈生,何强,等。武汉2019冠状病毒病住院患者神经系统特征分析中华医学杂志,2020;77:683-90。5. Sharifi‐Razavi A, Karimi N, Rouhani N. COVID‐19与脑出血:是因果关系还是巧合?中国生物医学工程学报(英文版);2009;31(5):591 - 591。6. 比尔JC。肠病毒和其他病毒性脑膜炎患者颅内压升高。中华神经科杂志,2017;17(2):444 - 444。7. Svedung Wettervik T, Kumlien E, Rostami E, Howells T, von Seth M, Velickaite V,等。2019冠状病毒病合并急性脑炎患者颅内压动态及脑血管舒缩反应性中国生物医学工程学报(英文版);2020;29(1):391 - 391。8. Noro F, Cardoso FM, Marchiori E.。COVID-19与良性颅内高压1例报告。中国生物医学工程学报,2014;33(2):591 - 591。9. Bhaskar S, Bradley S, israel - korn S, Menon B, Chattu VK, Thomas P,等。COVID-19时代的慢性神经病学:REPROGRAM联盟的临床考虑和建议。中华医学杂志2020;11:664。10. 劳伦森JG,巴克利RJ。COVID-19和眼睛。中国眼科杂志,2020;40(3):388 - 388。11. 脑外伤基金会,美国神经外科医师协会,神经外科医师大会,神经外伤与重症监护联合分会,AANS/CNS, Bratton SL, Chestnut RM等。严重创伤性脑损伤处理指南。六、颅内压监测指征。中华神经科杂志(英文版);2009;31(1):337 - 344。亲爱的编辑,
{"title":"Optic Nerve Ultrasonography for Noninvasive Monitoring of Intracranial Pressure in COVID-19 Patients","authors":"L. Moscote-Salazar, Tariq Janjua, A. Agrawal","doi":"10.4103/jtccm.jtccm_11_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_11_20","url":null,"abstract":"century. Pediatr Res 2004;56:1-5. 3. Al Hajjar S, McIntosh K. The first influenza pandemic of the 21st century. Ann Saudi Med 2010;30:1-0. 4. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-90. 5. Sharifi‐Razavi A, Karimi N, Rouhani N. COVID‐19 and intracerebral haemorrhage: Causative or coincidental? New Microbes New Infect 2020;35:100669. 6. Beal JC. Increased intracranial pressure in the setting of Enterovirus and other viral meningitides. Neurol Res Int 2017;2017:2854043. 7. Svedung Wettervik T, Kumlien E, Rostami E, Howells T, von Seth M, Velickaite V, et al. Intracranial pressure dynamics and cerebral vasomotor reactivity in coronavirus disease 2019 patient with acute encephalitis. Crit Care Explor 2020;2:e0197. 8. Noro F, Cardoso FM, Marchiori E. COVID-19 and benign intracranial hypertension: A case report. Rev Soc Bras Med Trop 2020;53:e20200325. 9. Bhaskar S, Bradley S, Israeli-Korn S, Menon B, Chattu VK, Thomas P, et al. Chronic neurology in COVID-19 era: Clinical considerations and recommendations from the REPROGRAM consortium. Front Neurol 2020;11:664. 10. Lawrenson JG, Buckley RJ. COVID-19 and the eye. Ophthalmic Physiol Opt 2020;40:383-8. 11. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, et al. Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring. J Neurotrauma 2007;24 Suppl 1:S37-44. Dear Editor,","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"9 1","pages":"21 - 21"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76352097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Pulmonary Embolism Secondary to Pacemaker Insertion 继发于心脏起搏器植入的急性肺栓塞
Pub Date : 2020-01-01 DOI: 10.4103/jtccm.jtccm_12_20
J. Prakash, Rashmi Kujur, R. Kharwar, Amit Gupta
Acute pulmonary embolism is an uncommon complication after pacemaker insertion. This report describes, in view of multiple finding, we found the exact cause of the present scenario of the patient which is rare and successfully managed.
摘要急性肺栓塞是心脏起搏器植入后的罕见并发症。本报告描述,鉴于多重发现,我们找到了确切的原因,目前的情况下,这是罕见的,成功地管理的病人。
{"title":"Acute Pulmonary Embolism Secondary to Pacemaker Insertion","authors":"J. Prakash, Rashmi Kujur, R. Kharwar, Amit Gupta","doi":"10.4103/jtccm.jtccm_12_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_12_20","url":null,"abstract":"Acute pulmonary embolism is an uncommon complication after pacemaker insertion. This report describes, in view of multiple finding, we found the exact cause of the present scenario of the patient which is rare and successfully managed.","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"66 1","pages":"18 - 20"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74129306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indices of Tissue Perfusion: Triggers of Targets of Resuscitation? 组织灌注指标:复苏目标的触发因素?
Pub Date : 2020-01-01 DOI: 10.4103/jtccm.jtccm_1_20
D. De Backer, M. Van Hove, P. Foulon, J. Kadou, Grégoire Michiels, S. Giglioli
Circulatory shock is characterized by a decrease in oxygen delivery to the tissues associated with impairment in oxygen metabolism and tissue hypoxia. Clinical and biological signs of impaired tissue perfusion and tissue hypoxia are used as bedside to detect circulatory failure and trigger resuscitation procedures. The most popular signs of tissue hypoperfusion include mean arterial pressure, capillary refill time and mottling score, central venous oxygen saturation (ScvO2), veno-arterial difference in PCO2 (PvaCO2), microcirculation assessment, and lactate. Both the severity and duration of the alterations in any of these variables are associated with a poor outcome so that it sounds logical to trigger therapy based on these. Using these variables as target for therapy is much more complex. Some of the limits for using some of these variables as targets include an incertitude about the target to reach (should we aim at normalizing or improving the variable, and by how much?) and the time lag between resolution of impaired tissue perfusion/hypoxia and normalization of the variable. The ideal target variable should have a well-defined end point and a rapid response time. Interestingly, hemodynamic resuscitation targeting these variables gave variable results. In this review, we will discuss the interest and limitations of the above-mentioned indices of tissue perfusion and hypoxia as trigger as well as end point of resuscitation in critically ill patients.
循环性休克的特点是与氧代谢障碍和组织缺氧相关的组织氧输送减少。组织灌注受损和组织缺氧的临床和生物学迹象被用作床边检测循环衰竭和触发复苏程序。组织灌注不足最常见的症状包括平均动脉压、毛细血管再灌注时间和斑驳评分、中心静脉氧饱和度(ScvO2)、静脉-动脉PCO2差(PvaCO2)、微循环评估和乳酸水平。这些变量变化的严重程度和持续时间都与不良结果相关,因此基于这些变量触发治疗听起来是合乎逻辑的。使用这些变量作为治疗目标要复杂得多。使用其中一些变量作为目标的一些限制包括目标达到的不确定性(我们的目标是正常化还是改善变量,以及改善多少?)以及受损组织灌注/缺氧的解决与变量正常化之间的时间滞后。理想的目标变量应该有明确的终点和快速的响应时间。有趣的是,针对这些变量的血流动力学复苏产生了不同的结果。在这篇综述中,我们将讨论上述组织灌注和缺氧指标作为危重患者复苏的触发点和终点的兴趣和局限性。
{"title":"Indices of Tissue Perfusion: Triggers of Targets of Resuscitation?","authors":"D. De Backer, M. Van Hove, P. Foulon, J. Kadou, Grégoire Michiels, S. Giglioli","doi":"10.4103/jtccm.jtccm_1_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_1_20","url":null,"abstract":"Circulatory shock is characterized by a decrease in oxygen delivery to the tissues associated with impairment in oxygen metabolism and tissue hypoxia. Clinical and biological signs of impaired tissue perfusion and tissue hypoxia are used as bedside to detect circulatory failure and trigger resuscitation procedures. The most popular signs of tissue hypoperfusion include mean arterial pressure, capillary refill time and mottling score, central venous oxygen saturation (ScvO2), veno-arterial difference in PCO2 (PvaCO2), microcirculation assessment, and lactate. Both the severity and duration of the alterations in any of these variables are associated with a poor outcome so that it sounds logical to trigger therapy based on these. Using these variables as target for therapy is much more complex. Some of the limits for using some of these variables as targets include an incertitude about the target to reach (should we aim at normalizing or improving the variable, and by how much?) and the time lag between resolution of impaired tissue perfusion/hypoxia and normalization of the variable. The ideal target variable should have a well-defined end point and a rapid response time. Interestingly, hemodynamic resuscitation targeting these variables gave variable results. In this review, we will discuss the interest and limitations of the above-mentioned indices of tissue perfusion and hypoxia as trigger as well as end point of resuscitation in critically ill patients.","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"32 1","pages":"1 - 9"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86822599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Procalcitonin to Facilitate Early Detection of Co-Infection during Flu in Critically Ill Immunosuppressed Patients: We Are Not Sure 降钙素原有助于在危重免疫抑制患者流感期间早期发现合并感染:我们不确定
Pub Date : 2020-01-01 DOI: 10.4103/jtccm.jtccm_8_20
P. Honore, A. Mugisha, L. Kugener, S. Redant, R. Attou, A. Gallerani, D. Bels
{"title":"Procalcitonin to Facilitate Early Detection of Co-Infection during Flu in Critically Ill Immunosuppressed Patients: We Are Not Sure","authors":"P. Honore, A. Mugisha, L. Kugener, S. Redant, R. Attou, A. Gallerani, D. Bels","doi":"10.4103/jtccm.jtccm_8_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_8_20","url":null,"abstract":"","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"22 1","pages":"22 - 22"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90500704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective Evaluation and Analysis of Postoperative Admissions in the Intensive Care Unit of a Tertiary Care Hospital: An Indian Update 一家三级医院重症监护室术后入院的前瞻性评估和分析:印度的最新情况
Pub Date : 2019-10-01 DOI: 10.4103/jtccm.jtccm_6_20
Vijay Singh, R. Datta, S. Sasidharan, Lalit Tomar, M. Babitha
Introduction: The characteristics for the planned ICU admissions were not surprising. However, the reasons for unplanned ICU admission are multi-factorial and may be beyond the scope of the anaesthesiologist's role in patient care. Unplanned intensive care admission may be a useful indicator of the quality of the overall process of peri-operative care. With this background, this study was undertaken to do a prospective evaluation, analysis of post-op admissions in the Intensive Care Unit of a tertiary care hospital. Material and Methods: The present observational study was conducted in the Intensive Care Unit of a defence Tertiary Care Hospital for a period of one-year wef 1Apr 18 to 31 March 19 and all the post-operative patients were divided into two groups: Group 1 – Planned Admissions: This included those patients where surgeon and/or the anaesthesiologist had decided pre-operatively for post-op ICU admission. Group 2 – Unplanned Admissions and Emergency admission: This included those patients, whose admissions were not anticipated pre-operatively, however, due to some unexpected peri-op complications arising within 48 hours of surgery led them to ICU admission. This group also comprised of patients who were admitted after forty-eight hours of primary surgery for post-operative complications. Result: In one year, the total operated patients (excluding paediatric, cardiac) in various OTs were 18157 and out of which, 261 patients were admitted to ICU. In planned group, maximum patients were of ASA III and in unplanned/emergency admissions ASA II patients were predominant. Post-operative gastrointestinal surgery patients formed a substantial percentage of the ICU admissions in both planned (94/211; 44.55%) and unplanned admission (20/50; 40.00%). GA with endotracheal intubation was technique of anaesthesia in both planned and unplanned admission. The predominant reason for unplanned ICU admission was post-operative care and treatment following unanticipated intra-operative complications. Conclusion: Thorough pre-operative evaluation and pre-operative optimization of patients whenever possible can reduce the incidence of unplanned admission to ICU. Early recognition of complications, timely intervention and timely intensive care and monitoring are essential to improve outcomes.
引言:ICU计划入院的特点并不令人惊讶。然而,意外入住ICU的原因是多因素的,可能超出了麻醉师在患者护理中的作用范围。计划外的重症监护入院可能是围手术期护理整体过程质量的有用指标。在此背景下,本研究旨在对某三级医院重症监护室的术后住院患者进行前瞻性评估和分析。材料和方法:本观察性研究于2018年4月1日至2019年3月31日在某国防三级医院重症监护室进行,为期一年,所有术后患者分为两组:1组-计划入院:包括外科医生和/或麻醉师术前决定术后入住ICU的患者。第2组-意外入院和急诊入院:这包括术前未预料到入院的患者,但由于手术48小时内出现一些意外的围手术期并发症导致他们入院ICU。该组也包括因术后并发症而在初次手术48小时后入院的患者。结果:1年内各类门诊共手术患者18157例(不含儿科、心脏科),其中ICU住院261例。在计划组中,ASA III型患者最多,而在非计划/急诊入院的患者中,ASA II型患者占主导地位。术后胃肠道手术患者在两项计划(94/211;44.55%)和计划外入院(20/50;40.00%)。气管插管加GA是计划入院和非计划入院的麻醉技术。非计划住院ICU的主要原因是术后护理和治疗的意外的术中并发症。结论:尽可能对患者进行全面的术前评估和术前优化,可减少非计划入住ICU的发生率。早期发现并发症、及时干预、及时重症监护和监测对改善预后至关重要。
{"title":"Prospective Evaluation and Analysis of Postoperative Admissions in the Intensive Care Unit of a Tertiary Care Hospital: An Indian Update","authors":"Vijay Singh, R. Datta, S. Sasidharan, Lalit Tomar, M. Babitha","doi":"10.4103/jtccm.jtccm_6_20","DOIUrl":"https://doi.org/10.4103/jtccm.jtccm_6_20","url":null,"abstract":"Introduction: The characteristics for the planned ICU admissions were not surprising. However, the reasons for unplanned ICU admission are multi-factorial and may be beyond the scope of the anaesthesiologist's role in patient care. Unplanned intensive care admission may be a useful indicator of the quality of the overall process of peri-operative care. With this background, this study was undertaken to do a prospective evaluation, analysis of post-op admissions in the Intensive Care Unit of a tertiary care hospital. Material and Methods: The present observational study was conducted in the Intensive Care Unit of a defence Tertiary Care Hospital for a period of one-year wef 1Apr 18 to 31 March 19 and all the post-operative patients were divided into two groups: Group 1 – Planned Admissions: This included those patients where surgeon and/or the anaesthesiologist had decided pre-operatively for post-op ICU admission. Group 2 – Unplanned Admissions and Emergency admission: This included those patients, whose admissions were not anticipated pre-operatively, however, due to some unexpected peri-op complications arising within 48 hours of surgery led them to ICU admission. This group also comprised of patients who were admitted after forty-eight hours of primary surgery for post-operative complications. Result: In one year, the total operated patients (excluding paediatric, cardiac) in various OTs were 18157 and out of which, 261 patients were admitted to ICU. In planned group, maximum patients were of ASA III and in unplanned/emergency admissions ASA II patients were predominant. Post-operative gastrointestinal surgery patients formed a substantial percentage of the ICU admissions in both planned (94/211; 44.55%) and unplanned admission (20/50; 40.00%). GA with endotracheal intubation was technique of anaesthesia in both planned and unplanned admission. The predominant reason for unplanned ICU admission was post-operative care and treatment following unanticipated intra-operative complications. Conclusion: Thorough pre-operative evaluation and pre-operative optimization of patients whenever possible can reduce the incidence of unplanned admission to ICU. Early recognition of complications, timely intervention and timely intensive care and monitoring are essential to improve outcomes.","PeriodicalId":93326,"journal":{"name":"Journal of Translational Critical Care Medicine","volume":"36 1","pages":"127 - 134"},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84842763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Translational Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1